The University of Oxford and Novo Nordisk today announced a landmark research collaboration focused on type 2 diabetes. The partnership will enable scientists from Novo Nordisk and the University of Oxford to collaborate to discover innovative approaches for treating type 2 diabetes. As part of the collaboration, Novo Nordisk is also investing in a new research centre on the premises of the University of Oxford.
Novo Nordisk enters collaboration with University of Oxford on type 2 diabetes
- 30 January 2017
International research company Novo Nordisk is investing £115 million in a new research centre at the University of Oxford, as part of a new type 2 diabetes research collaboration with the University.